Individual holder
DONOVAN DAVID M
US·7 granted patents·26 citations·filing 2009–2012
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
7 records- 0190US8481289B2Triple acting antimicrobials that are refractory to resistance developmentDONOVAN DAVID M·Filed 2009·Granted Jul 9, 2013·12 cites·10 claims
- 0287US8568714B2Lys K endolysin is synergistic with lysostaphin against MRSADONOVAN DAVID M·Filed 2009·Granted Oct 29, 2013·8 cites·8 claims
- 0382US9545431B1Isolated recombinant cDNADONOVAN DAVID M·Filed 2009·Granted Jan 17, 2017·2 cites·12 claims
- 0468US9206411B2Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureusDONOVAN DAVID M·Filed 2012·Granted Dec 8, 2015·1 cites·8 claims
- 0565US8790639B2Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysinDONOVAN DAVID M·Filed 2012·Granted Jul 29, 2014·2 cites·17 claims
- 0659US8986695B2Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5DONOVAN DAVID M·Filed 2011·Granted Mar 24, 2015·1 cites·13 claims
- 0737US8980614B2Staphylococcus haemolyticus prophage φSH2 endolysin is lytic for Staphylococcus aureusDONOVAN DAVID M·Filed 2012·Granted Mar 17, 2015·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when DONOVAN DAVID M files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →